Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
38,550,447
-
Share change
-
-666,176
-
Total reported value
-
$31,261,000
-
Put/Call ratio
-
15%
-
Price per share
-
$0.81
-
Number of holders
-
51
-
Value change
-
-$32,629,826
-
Number of buys
-
24
-
Number of sells
-
48
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q3 2015
As of 30 Sep 2015,
SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,550,447 shares.
The largest 10 holders included
Palo Alto Investors, LLC, NEA Management Company, LLC, FMR LLC, GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, FARALLON CAPITAL MANAGEMENT LLC, BVF INC/IL, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.